Log in

NASDAQ:MBOT - Microbot Medical Stock Price, Forecast & News

$9.54
-0.10 (-1.04 %)
(As of 02/27/2020 06:00 AM ET)
Today's Range
$9.31
Now: $9.54
$9.82
50-Day Range
$8.10
MA: $10.29
$13.17
52-Week Range
$4.48
Now: $9.54
$20.15
Volume177,652 shs
Average Volume859,649 shs
Market Capitalization$59.96 million
P/E RatioN/A
Dividend YieldN/A
Beta5.45
Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MBOT
CUSIPN/A
Phone781-875-3605

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.40 per share

Profitability

Net Income$-7,240,000.00

Miscellaneous

Employees9
Market Cap$59.96 million
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable

Receive MBOT News and Ratings via Email

Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.


Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions

What is Microbot Medical's stock symbol?

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

When did Microbot Medical's stock split? How did Microbot Medical's stock split work?

Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc (NASDAQ:MBOT) posted its quarterly earnings data on Wednesday, November, 14th. The biotechnology company reported ($0.58) earnings per share for the quarter, beating analysts' consensus estimates of ($0.60) by $0.02. View Microbot Medical's Earnings History.

When is Microbot Medical's next earnings date?

Microbot Medical is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Microbot Medical.

What price target have analysts set for MBOT?

1 brokers have issued 12-month price objectives for Microbot Medical's stock. Their forecasts range from $26.00 to $26.00. On average, they anticipate Microbot Medical's stock price to reach $26.00 in the next twelve months. This suggests a possible upside of 172.5% from the stock's current price. View Analyst Price Targets for Microbot Medical.

What is the consensus analysts' recommendation for Microbot Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Microbot Medical.

What are Wall Street analysts saying about Microbot Medical stock?

Here are some recent quotes from research analysts about Microbot Medical stock:
  • 1. According to Zacks Investment Research, "Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA. " (1/1/2020)
  • 2. HC Wainwright analysts commented, "Our price target is derived from an estimated market value of the firm at $60M, which includes a discounted cash flow (DCF)-based asset value of SCS, assuming 60% probability of approval, 20% discount rate and 2% terminal growth rate." (9/11/2019)

Has Microbot Medical been receiving favorable news coverage?

Press coverage about MBOT stock has trended positive recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Microbot Medical earned a news sentiment score of 2.4 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Microbot Medical.

Who are some of Microbot Medical's key competitors?

What other stocks do shareholders of Microbot Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Novavax (NVAX), Athersys (ATHX), Gilead Sciences (GILD), NVIDIA (NVDA), Sarepta Therapeutics (SRPT), NovaBay Pharmaceuticals (NBY), Micron Technology (MU) and AcelRx Pharmaceuticals (ACRX).

Who are Microbot Medical's key executives?

Microbot Medical's management team includes the folowing people:
  • Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 46)
  • Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 50)
  • Dr. Simon Sharon, CTO & Chairman of Scientific Advisory Board
  • Prof. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 67)
  • Dr. Eric C. Leuthardt, Scientific Director & Member of Scientific Advisory Board

Who are Microbot Medical's major shareholders?

Microbot Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (3.00%), Virtu Financial LLC (0.95%) and Sunbelt Securities Inc. (0.03%). View Institutional Ownership Trends for Microbot Medical.

Which major investors are selling Microbot Medical stock?

MBOT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Microbot Medical.

Which major investors are buying Microbot Medical stock?

MBOT stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC and Sunbelt Securities Inc.. View Insider Buying and Selling for Microbot Medical.

How do I buy shares of Microbot Medical?

Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Microbot Medical's stock price today?

One share of MBOT stock can currently be purchased for approximately $9.54.

How big of a company is Microbot Medical?

Microbot Medical has a market capitalization of $59.96 million. The biotechnology company earns $-7,240,000.00 in net income (profit) each year or ($2.41) on an earnings per share basis. Microbot Medical employs 9 workers across the globe.View Additional Information About Microbot Medical.

What is Microbot Medical's official website?

The official website for Microbot Medical is http://www.microbotmedical.com/.

How can I contact Microbot Medical?

Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]


MarketBeat Community Rating for Microbot Medical (NASDAQ MBOT)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  331 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  588
MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel